Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Inovio Pharma
(NQ:
INO
)
7.220
-0.100 (-1.37%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Inovio Pharma
< Previous
1
2
3
4
5
6
7
8
9
Next >
INO Stock: The Covid-19 Vaccine News Helping Inovio Power Higher
November 09, 2021
Inovio Pharmaceuticals (INO) stock is pushing higher on Tuesday after providing investors with an update on its Covid-19 vaccine.
Via
InvestorPlace
Exposures
COVID-19
FDA Lifts Clinical Hold On Inovio's COVID-19 Vaccine Trial
November 09, 2021
The FDA has lifted a partial clinical hold on a late-stage trial of Inovio Pharmaceuticals Inc's (NASDAQ: INO) COVID-19 vaccine in the U.S. Inovio said it...
Via
Benzinga
Exposures
COVID-19
Product Safety
Rising Test Accuracy Standards Needed as On-Site Demand for Covid-19 Testing Increases
November 09, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –November 9, 2021 – USA News Group – After the launch of US President Joe Biden’s pushing of mandatory vaccination/testing in the...
Via
FinancialNewsMedia
Exposures
COVID-19
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
November 09, 2021
Gainers Compass Pathways (NASDAQ:CMPS) shares rose 18.43% to $51.0 during Tuesday's pre-market session. The company's market cap stands at $2.1 billion. As per the...
Via
Benzinga
The Daily Biotech Pulse: Double Dose Of Positive Tidings For Merck, Alkermes Slips On Partial Termination Of J&J Licensing Deal, Amgen Migraine Drug Data
November 09, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Merck Gets Antitrust Nod For Acceleron Deal In Germany, Austria, Announces...
Via
Benzinga
AstraZeneca's Medimmune Terminates DNA Cancer Vaccine Program With Inovio
November 01, 2021
MedImmune Limited, a unit of AstraZeneca Plc (NASDAQ: AZN), has notified Inovio Pharmaceuticals Inc (NASDAQ: INO) to terminate the DNA cancer vaccine...
Via
Benzinga
The Week Ahead In Biotech (Nov. 7-Nov. 13): Earnings Taper Off, Multiple Conference Presentations, IPOs And More
November 08, 2021
Biotech stocks reversed course and closed the week ended Nov. 5 lower, squandering the gains notched early in the week. What was good news for Pfizer, Inc. (NYSE: PFE) turned out...
Via
Benzinga
Vaccine Makers Slump As Oral Antivirals Begin To Take Center Stage
October 18, 2021
Vaccine makers have been under tremendous selling pressure over the past 2 months driven by policy, the rising delta wave, and breakthrough infections. This slump has been a boost for the oral...
Via
Talk Markets
Scientific Reports Revealing Early Promise for Universal Coronavirus Vaccine
October 20, 2021
Palm Beach, FL – October 20, 2021 – FinancialNewsMedia.com News Commentary – Recently, scientific reports have shown that a universal coronavirus vaccine that protects against COVID-19 causing...
Via
FinancialNewsMedia
Exposures
COVID-19
Is This The Turning Point for Inovio?
October 06, 2021
The biotech's streak of bad luck may be about to end, but risks remain.
Via
The Motley Fool
Exposures
COVID-19
New Covid-19 Vaccines Continue to Be Developed by Biotech Firms Seeking to Improve the Jab
October 06, 2021
FN Media Group Presents USA News Group News Commentary Vancouver, BC –October 6, 2021 – USA News Group – As vaccine passport programs continue to roll out in new markets across the globe, especially in...
Via
FinancialNewsMedia
Exposures
COVID-19
Is Vaccine Latecomer Inovio Making a Comeback?
September 29, 2021
Its new plan for phase 3 trials is advancing.
Via
The Motley Fool
Exposures
COVID-19
As the Virus Continues, the Global Covid-19 Vaccine Market Expected to Reach $25 Billion By 2024
September 23, 2021
Via
FinancialNewsMedia
Exposures
COVID-19
Looking Into Inovio Pharmaceuticals's Return On Capital Employed
September 16, 2021
Inovio Pharmaceuticals (NASDAQ:INO) brought in sales totaling $272.82 thousand during Q2 according to data provided by Benzinga Pro. However, earnings decreased 58.32%, resulting...
Via
Benzinga
Etsy And NetApp Lead The S&P 500
August 26, 2021
U.S. indices were trading lower Thursday as traders await signs of Fed tapering policy. Explosions outside of Kabul airport in Afghanistan has also caused macro uncertainty and...
Via
Benzinga
Topics
Economy
Stocks
Exposures
Interest Rates
US Equities
Why Inovio Stock Is Jumping Today
August 26, 2021
The vaccine maker received some good news from Brazil.
Via
The Motley Fool
Exposures
COVID-19
Inovio Pharmaceuticals Stock Nears End Of Technical Pattern
August 26, 2021
Inovio Pharmaceuticals Inc. (NASDAQ:INO) shares are trading...
Via
Benzinga
Inovio To Start Global Late-Stage COVID-19 Vaccine Trial
August 26, 2021
The regulatory authority of Brazil has signed off Inovio Pharmaceuticals Inc's (NASDAQ: INO) global Phase 3 segment of its INNOVATE Phase 2/3 trial for INO-...
Via
Benzinga
Exposures
COVID-19
Why Inovio's Stock Is Trading Higher Today
August 26, 2021
Inovio Pharmaceuticals Inc (NASDAQ: INO) is trading higher Thursday after the company announced it received regulatory authorization from Brazil's ANVISA to initiate the...
Via
Benzinga
2 Popular Robinhood Stocks I Wouldn't Buy With Free Money
August 25, 2021
Not every stock on the popular trading app is worth owning.
Via
The Motley Fool
Why Dynavax, Novavax, and Inovio Stocks Sank This Week
August 20, 2021
Investors appeared to be rattled by the U.S. government's decision to move forward with booster doses of mRNA vaccines.
Via
The Motley Fool
Exposures
COVID-19
Unusual Options Activity Insight: Inovio Pharmaceuticals
August 18, 2021
On Wednesday, shares of Inovio Pharmaceuticals (NASDAQ:INO) saw unusual options activity. After the option alert, the stock price moved down to $8.29. Sentiment: BULLISH Option...
Via
Benzinga
3 Scary COVID Stocks to Avoid
August 17, 2021
Our Fool roundtable picks three COVID stocks they think are dangerous at these prices.
Via
The Motley Fool
Exposures
COVID-19
Apple And Salesforce Lead The DIA In A Mixed Day Of Trading
August 12, 2021
U.S. indices had a mixed day of trading Thursday as traders and investors weigh COVID-19 variant updates, recent earnings and the recently passed $1 trillion...
Via
Benzinga
Exposures
COVID-19
77 Biggest Movers From Yesterday
August 13, 2021
Gainers Powerbridge Technologies Co., Ltd. (NASDAQ: PBTS) shares surged 65.4% to close at $2.10 on Thursday after the company announced it is expanding its blockchain business to...
Via
Benzinga
Watch Out: Inovio Pharmaceuticals Is Heating Up
August 12, 2021
Inovio Pharmaceuticals Inc. (NASDAQ: INO) shares are trading higher Thursday alongside other vaccine maker stocks. Stocks have been trading higher recently as the COVIS-19 delta...
Via
Benzinga
85 Biggest Movers From Yesterday
August 11, 2021
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) jumped 125.3% to close at $18.77 on Tuesday after the company announced positive interim results from the Phase 1 trial with FTX...
Via
Benzinga
Why Inovio Pharmaceuticals Is Plunging Today
August 10, 2021
Solid business developments did not please investors.
Via
The Motley Fool
Exposures
COVID-19
Why Inovio's Stock Is Trading Lower Today
August 10, 2021
Inovio Pharmaceuticals Inc (NASDAQ: INO) shares are trading lower by 9.9% at $8.65 after the company reported worse-than-expected second-quarter EPS and sales results....
Via
Benzinga
54 Stocks Moving In Tuesday's Mid-Day Session
August 10, 2021
Gainers Fulcrum Therapeutics, Inc. (NASDAQ: FULC) climbed 79.3% to $14.93 after the company announced positive interim results from the Phase 1 trial with FTX-6058 in healthy...
Via
Benzinga
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.